Norovirus waterborne outbreak in Chalkidiki, Greece, 2015: detection of GI.P2_GI.2 and GII.P16_GII.13 unusual strains.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 3 4 2020
Statut: ppublish

Résumé

Noroviruses, along with rotaviruses, are among the leading causes of gastroenteritis worldwide and novel strains are periodically emerging. In August 2015, an unusual increase of gastroenteritis cases occurred in a touristic district in Kassandra peninsula, Chalkidiki, Northern Greece. Seven stool specimens from cases were tested positive for norovirus. Molecular investigation and phylogenetic analysis identified that there was co-circulation of norovirus GI.P2_GI.2 and the recombinant strain GII.P16_GII.13. A 1:1 case-control study conducted and showed that tap water consumption significantly associated with developing symptoms of gastroenteritis (odds ratio = 36.9, P = 0.018). The results of the epidemiological investigation, the co-circulation of two different norovirus strains, the information of a pipeline breakage at the water supply system before the onset of cases, and reports on flooded wells and sewage overflow, indicated the possibility of water contamination by sewage during the pipeline breakage leading to a large outbreak with a peak at 10 August and a possible secondary person-to-person transmission after the 16th of August. Norovirus GI.P2_GI.2 strains are rarely reported in Europe, while it is the first time that infection from the recombinant strain GII.P16_GII.13 is recorded in Greece.

Identifiants

pubmed: 31364530
pii: S0950268819000852
doi: 10.1017/S0950268819000852
pmc: PMC6625189
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e227

Références

J Clin Virol. 2006 Jan;35(1):84-8
pubmed: 16242995
Int J Epidemiol. 2007 Aug;36(4):873-80
pubmed: 17389718
J Med Virol. 2009 May;81(5):922-32
pubmed: 19319938
J Clin Virol. 2009 Jul;45(3):223-9
pubmed: 19464942
J Clin Microbiol. 2009 Aug;47(8):2411-8
pubmed: 19494060
J Clin Virol. 2010 Mar;47(3):268-72
pubmed: 20056481
Euro Surveill. 2010 Mar 25;15(12):null
pubmed: 20350499
Environ Sci Technol. 2010 Nov 15;44(22):8561-6
pubmed: 20968297
Sci Total Environ. 2011 May 1;409(11):2078-84
pubmed: 21440930
Infect Genet Evol. 2011 Oct;11(7):1716-26
pubmed: 21803173
Appl Environ Microbiol. 2012 Mar;78(6):1846-52
pubmed: 22247153
Epidemiol Infect. 2012 Jul;140(7):1161-72
pubmed: 22444943
Epidemiol Infect. 2013 Aug;141(8):1563-71
pubmed: 23433247
Arch Virol. 2013 Oct;158(10):2059-68
pubmed: 23615870
Emerg Infect Dis. 2013 Aug;19(8):1305-9
pubmed: 23876187
Food Environ Virol. 2013 Jul 26;:null
pubmed: 23888384
Virus Genes. 2014 Feb;48(1):23-31
pubmed: 24142407
Mol Cell Probes. 2014 Aug;28(4):204-10
pubmed: 24751495
Virus Res. 2014 Aug 8;188:142-5
pubmed: 24751799
Clin Microbiol Infect. 2014 Aug;20(8):724-30
pubmed: 24943671
J Clin Microbiol. 2015 Feb;53(2):373-81
pubmed: 24989606
J Med Virol. 2015 May;87(5):740-53
pubmed: 25693507
PLoS Curr. 2016 Oct 4;8:
pubmed: 27803839
Clin Microbiol Infect. 2017 Apr;23(4):265.e9-265.e13
pubmed: 28003123
Water Res. 2017 Oct 1;122:503-511
pubmed: 28624733
Sci Rep. 2017 Jul 10;7(1):4976
pubmed: 28694427
Lancet Infect Dis. 2018 May;18(5):545-553
pubmed: 29396001

Auteurs

K Tryfinopoulou (K)

Hellenic Centre for Diseases Control and Prevention, Department of Surveillance and Intervention,Athens,Greece.

M Kyritsi (M)

Department of Hygiene and Epidemiology,Medical School, University of Thessaly,Larissa,Greece.

K Mellou (K)

Hellenic Centre for Diseases Control and Prevention, Department of Surveillance and Intervention,Athens,Greece.

F Kolokythopoulou (F)

Department of Hygiene and Epidemiology,Medical School, University of Thessaly,Larissa,Greece.

V A Mouchtouri (VA)

Department of Hygiene and Epidemiology,Medical School, University of Thessaly,Larissa,Greece.

M Potamiti-Komi (M)

Hellenic Centre for Diseases Control and Prevention, Department of Surveillance and Intervention,Athens,Greece.

A Lamprou (A)

Hellenic Centre for Diseases Control and Prevention, Department of Surveillance and Intervention,Athens,Greece.

Th Georgakopoulou (T)

Hellenic Centre for Diseases Control and Prevention, Department of Surveillance and Intervention,Athens,Greece.

C Hadjichristodoulou (C)

Department of Hygiene and Epidemiology,Medical School, University of Thessaly,Larissa,Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH